D. E. Shaw & Co »

Liminatus Pharma shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Liminatus Pharma (LIMNW) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Liminatus Pharma

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $10k 83k 0.12
2025-06-30 $20k 83k 0.24

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Palantir Technologies Cl A Call Option (PLTR)
Micron Technology Put Option (MU)
Tesla Motors (TSLA)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Put Option (AAPL)
Netflix Put Option (NFLX)
Booking Holdings (BKNG)
Robinhood Mkts Com Cl A Put Option (HOOD)
Amazon (AMZN)
Western Digital Put Option (WDC)

View all positions for D. E. Shaw & Co

Top funds holding Liminatus Pharma

Clear Street
Aristeia Capital
Linden Advisors
Saba Capital Management
Highbridge Capital Management
Moore Capital Management
Polar Securities
MMCAP International Inc. SPC
Nomura Holdings
Falcon Edge Capital
D. E. Shaw & Co
Millennium Management
Wolverine Asset Management
Blue Owl Capital Holdings
Periscope Capital

View all funds holding Liminatus Pharma